Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-17

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original-application generic sacubitril/valsartan for the treatment of heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)